Clinical Trial: Efficacy Comparison and Safety Evaluation of BCMA-Targeted CAR-T Therapy versus Conventional Regimens in the Real-World Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Cohort Study (China)

Posted On: 2026-08-10

China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy Comparison and Safety Evaluation of BCMA-Targeted CAR-T Therapy versus Conventional Regimens in the Real-World Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Cohort Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129763

Registration Time: 2026/08/10

Type: Observational study

Primary Sponsor: Peking University Shenzhen Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336391

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy Comparison and Safety Evaluation of BCMA-Targeted CAR-T Therapy versus Conventional Regimens in the Real-World Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Cohort Study (China)